Intrauterine Injection
Intrauterine Injection - Related Videos
07:03
Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo
0 Views •
Cited by 16 •
2015
This manuscript provides a protocol for implanting telemeters in the mouse for the purpose of measuring intrauterine pressures during pregnancy.
11:44
Establishment of a Rat Model for Intrauterine Adhesions via Dual Injury: Curettage and Infection
0 Views •
Cited by 1 •
2025
Intrauterine adhesions (IUAs), the most common pathological consequence of endometrial injury, severely impair reproductive function. Trauma and infection are widely recognized as key risk factors for IUA development. We have successfully established a reproducible rat model of IUAs by combining two critical injury methods: mechanical curettage and infectious induction with lipopolysaccharide.
01:21
Intrauterine Drug Delivery Systems
0 Views •
2026
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
0 Views •
Cited by 11 •
2013
We describe examination of fetal cardiac function with contemporary functional fetal echocardiography and fetoplacental Doppler ultrasound using the VisualSonics VEVO 2100 microultrasound in a surgically induced model of intrauterine fetal growth restriction in a rabbit.
26:17
In Utero Intraventricular Injection and Electroporation of E15 Mouse Embryos
0 Views •
Cited by 53 •
2007
In-utero in-vivo injection and electroporation of the embryonic mouse neocortex provides a powerful tool for the manipulation of individual progenitors ...
FAQs
Placing a substance within the uterus brings it closer to the intended site of action, which may increase local exposure compared with broader administration. This localized delivery may also reduce the need for systemic treatment. The actual benefit depends on the injected substance, the uterine target, the technique used, and the clinical indication being addressed.
Ultrasound imaging helps clinicians control the needle’s placement as it passes through the cervix or uterine wall. This guidance can support accurate delivery to the uterine cavity or tissue while helping limit injury to nearby structures. Its value is especially relevant when precise positioning affects the intended local exposure or the safety of the procedure.
The two approaches place the material in different anatomical locations. Cavity delivery positions the substance within the uterine space, whereas tissue delivery places it directly into uterine tissue. This distinction can influence where exposure occurs and how the intervention is applied. The appropriate location depends on the substance, intended action, and clinical indication.
Safety and effectiveness depend on several linked factors: the substance being delivered, the route and placement selected, the injection technique, and the reason for treatment. Accurate control of the needle may help limit injury, while appropriate targeting supports local exposure. Because these variables differ among interventions, outcomes cannot be assumed across all uses.
A clinician first identifies the intended uterine target and selects the substance appropriate to the indication. A fine needle is then guided through the cervix or uterine wall, often with ultrasound imaging, to control its position. The material is delivered at the selected site, with attention to placement and avoidance of surrounding structures.
Potential uses include selected fertility procedures, localized delivery of therapeutic or diagnostic substances, and investigational approaches involving cells or biologic materials. These applications share an interest in placing material near a uterine target rather than relying solely on broader administration. Use remains dependent on the specific clinical indication and the intervention’s safety and effectiveness.
The technique may provide concentrated treatment exposure within the uterus and may reduce reliance on systemic administration. However, these potential advantages do not guarantee a favorable result. Outcomes depend on the injected material, placement, procedural technique, and clinical purpose. Safety and effectiveness therefore require consideration of the particular intervention rather than the method alone.